Experts present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.
OverviewIn an evolving healthcare environment with constant economic pressures, there is an increasing need to generate robust and actionable payer insights, beginning in the early stages of development and continuing all the way to post-launch. Actionable payer insights facilitate an informed approach to evidence generation that will be meaningful to payer, HTA, and medical decision-makers.
This webinar is designed to inform HEOR, RWE, and market access leads in pharmaceutical, biotech, and medical device companies.
Full DescriptionIn an evolving healthcare environment with constant economic pressures, clinical innovation alone is not sufficient to achieve optimal reimbursement and patient access.
Payers, regulators, and health technology assessment (HTA) agencies prioritize products that demonstrate the most compelling clinical benefit versus risk, as well as economic value, and increasingly are prioritizing benefits to patients.
Strategically timed payer insights can inform a relevant and timely evidence package and drug development strategy by defining the data required to support an optimal place in therapy/treatment pathways and by describing the value of the product in populations of unmet need. Understanding the evolving competitive and HTA landscape facilitates a forward-thinking approach to evidence strategies across the product lifecycle and increases the likelihood of optimal access.
In such a dynamic healthcare environment, the utilization of agile platforms and fit-for-purpose engagement models can drive an efficient and iterative approach to payer insights, evidence-synthesis, and evidence-generation. These approaches allow for flexibility and agility, and ensure that the process can be accelerated without compromising scientific rigor, facilitating the generation of evidence packages that are relevant and important for decision-makers.
Presenters
Priti Jhingran
With over two decades in the pharma industry, Priti Jhingran has focused on understanding evidence needs and delivering tools/solutions for access decision makers/HTAs. She has led multiple enterprise level initiatives; launched 15+ products; and developed diverse teams of scientists dedicated to the generation, dissemination, and communication of evidence.
Tijana Ignjatovic
Tijana Ignjatovic has over 15-years of consultancy experience within market access, having conducted over 100 pieces of research across a range of therapy areas during her time at MAT. This experience has given Tijana in-depth knowledge on how to optimize research methodologies to meet the strategic intent of payer research and provide actionable recommendations.
Sponsor
Genesis Research Group
Content Partners
HealthEconomics.com
HealthEconomics.com is the world’s largest Connected Community™ for Value, Evidence and Access in the life sciences industry.
HealthEconomics.com provides a single global link to the health economic and outcomes research (HEOR), real-world evidence (RWE), and Market Access (MA) stakeholder communities. Since 1993, we have provided unparalleled access to drive business, improve knowledge, and connect researchers and payer decision-makers world-wide.
Our 27,000 engaged readers rely on HealthEconomics.com as the most reliable, credible and curated digital hub for the latest news, insights, educational opportunities, and industry benchmarks in HEOR, RWE and MA. Our advertisers, numbering more than 500 with a 91% retention rate, depend upon HealthEconomics.com for best-in-class global brand awareness and business development solutions. Our aim is to connect people with expert-driven content and resources — all in one place — with the corporate mission to advance communication about healthcare value.
